Michael R Megna Kiniksa Pharmaceuticals, Ltd. (KNSA) insider trading activity

KNSA Quotes by TradingView

Michael R Megna is CHIEF ACCOUNTING OFFICER of Kiniksa Pharmaceuticals, Ltd.. Currently has a direct ownership of 27,046 shares of KNSA, which is worth approximately $1.01 Million. The most recent transaction as insider was on Dec 31, 2020, when has been sold 405 shares (Class A Common Share) at a price of $15.02 per share, resulting in proceeds of $6,083. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 27K
18.14% 3M change
1.95% 12M change
Total Value Held $1.01 Million

Michael R Megna Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 31 2020
BUY
Grant, award, or other acquisition
$6,083 $15.02 p/Share
405 Added 15.65%
2,183 Class A Common Share
Jun 30 2020
BUY
Grant, award, or other acquisition
$6,096 $9.51 p/Share
641 Added 26.5%
1,778 Class A Common Share
MRM

Michael R Megna

CHIEF ACCOUNTING OFFICER
Hamilton, D0

Track Institutional and Insider Activities on KNSA

Follow Kiniksa Pharmaceuticals, Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNSA shares.

Notify only if

Insider Trading

Get notified when an Kiniksa Pharmaceuticals, Ltd. insider buys or sells KNSA shares.

Notify only if

News

Receive news related to Kiniksa Pharmaceuticals, Ltd.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KNSA